(Q221520)

triamterene (English)

19 October 2016

chemical formula

C₁₂H₁₁N₇

1 reference

triamterene (English)

19 November 2016

canonical SMILES

C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N

1 reference

triamterene (English)

19 November 2016

defined daily dose

0.1 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=C03DB02

1 reference

14 February 2018

World Health Organisation international non-proprietary name

Triamterene (English)

1 reference

Triamterene (English)

medical condition treated

19 January 2016

1 reference

13 December 2016

arterial hypertension

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

increased blood creatinine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

acute kidney injury

1 reference

A reference set of clinically relevant adverse drug-drug interactions

thirst

1 reference

A reference set of clinically relevant adverse drug-drug interactions

asthenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

intention tremor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Delirium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Sodium channel epithelial 1 subunit beta

subject has role

channel blocker

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL585

Sodium channel epithelial 1 subunit gamma

subject has role

channel blocker

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL585

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

imported from Wikimedia project

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Triamterene

18 June 2015

1 reference

Medical Subject Headings

MeSH descriptor ID

D014223

Epithelial Sodium Channel Blockers

15 March 2018

1 reference

California Proposition 65 list of chemicals

Medical Subject Headings

15 March 2018

1 reference

19 March 2020

https://oehha.ca.gov/chemicals/triamterene

Commons category

Triamterene

0 references

Identifiers

InChI

InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)

1 reference

triamterene (English)

FNYLWPVRPXGIIP-UHFFFAOYSA-N

19 November 2016

InChIKey

2 references

triamterene (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

396-01-0

2 references

triamterene (English)

FNYLWPVRPXGIIP-UHFFFAOYSA-N

19 November 2016

InChIKey

9 April 2021

https://commonchemistry.cas.org/detail?cas_rn=396-01-0

1 reference

triamterene (English)

19 November 2016

1 reference

triamterene (English)

19 November 2016

ChEBI ID

9671

mapping relation type

exact match

1 reference

ChEBI release 2019-10-02

1 reference

MSBNK-Athens_Univ-AU110903

TRIAMTERENE (English)

19 November 2016

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU110904

0 references

MSBNK-Athens_Univ-AU110905

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003190

0 references

MSBNK-Waters-WA000614

0 references

MSBNK-Waters-WA000615

0 references

MSBNK-Waters-WA000616

0 references

MSBNK-Waters-WA000617

0 references

MSBNK-Waters-WA000618

0 references

SPLASH

splash10-000i-0590000000-b0551f41584c039101f6

0 references

splash10-00kf-0910000000-6428faa965a39a470ea5

0 references

splash10-0udi-0090000000-c1e38db82ca2bfb168b7

0 references

splash10-0udi-0090000000-e0b752d624dade8793ef

0 references

splash10-0udi-0090000000-4c12cffcdf72d196b590

0 references

splash10-0f79-0190000000-e63d14e64b8206d5c635

0 references

splash10-0f79-0970000000-a69efa072a4b5fca0463

0 references

splash10-0uxu-0910000000-f8ece9e1491b71df0c70

0 references

splash10-0uxu-3900000000-946796a2530a51263ccd

0 references

splash10-0f79-9600000000-59b671ef134dd8106331

0 references

splash10-0gw0-9200000000-3451a9c6dc2b3f4b6e3b

0 references

splash10-0udi-0090000000-c8bbcf103f5a3fdfebb5

0 references

splash10-0udi-0190000000-32f8b6872d5877d00316

0 references

0 references

1 reference

Hazardous Substances Data Bank

28 October 2019

Triamterene (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

0 references

206-904-3

1 reference

triamterene (English)

ECHA Substance Infocard ID

19 November 2016

100.006.278

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.006.278

27 December 2018

AICS Chemical ID (BEING DELETED)

Triamterene (English)

quotation

CAS no.: 396-01-0 (English)

0 references

1 reference

Guide to Pharmacology Ligand ID

Triamterene (English)

publication date

17 November 2015

4329

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

4329

triamterene (English)

19 November 2016

Triamterene

0 references

0 references

0 references

1 reference

triamterene (English)

19 November 2016

1 reference

Triamterene (English)

Human Metabolome Database ID

19 November 2016

HMDB0001940

1 reference

based on heuristic

inferred from InChIKey

1 reference

triamterene (English)

MedlinePlus drug identifier

19 November 2016

0 references

1 reference

triamterene (English)

19 November 2016

0 references

1 reference

1 reference

Immune Epitope Database and Analysis Resource

Triamterene (English)

19 January 2016

1 reference

1 March 2022

0 references

1 reference

California Proposition 65 list of chemicals

7 January 2020

https://oehha.ca.gov/chemicals/triamterene

0 references

1 reference

28 October 2013

Microsoft Academic ID

2777622974

0 references

museum-digital tag ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

imported from Wikimedia project

3JQ7 (English)

19 October 2016

1 reference

1 reference

triamterene (English)